PMA supplement
P210005 S002: IC-8 Apthera Intraocular Lens (IOL)
FDA PMA supplement · Normal 180 Day Track No User Fee · Acu Focus, Inc.
Key facts
| Original PMA | P210005 |
|---|---|
| Supplement number | S002 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | IC-8 Apthera Intraocular Lens (IOL) |
| Generic name | Extended depth of focus intraocular lens |
| Applicant | Acu Focus, Inc. |
| Product code | POE |
| Received date | Aug 23, 2022 |
| Decision date | Sep 20, 2022 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: